mobile search

Responses (April 2018)

 Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors

Institutions
 
Accountancy Firms
1.      Ernst & Young
2.      KPMG 
3.      PricewaterhouseCoopers
   
Corporate Finance Firms / Banks
4.      AJ International Holdings Limited
5. BOCI Asia Limited and ICBC International Holdings Limited (joint response)
6.  CITIC Securities 
7.  Chartwell Capital Limited 
8.  China International Capital Corporation Hong Kong Securities Limited (CICC)
9.  China Merchants Bank International 
10.  China Renaissance Securities (HK) Limited 
11.  China Securities International 
12.  CNCB (Hong Kong) Capital Ltd. 
13.  Dinova Capital 
14.  GES International AB 
15. HeungKong Capital Limited
16. Huatai Financial Holdings (Hong Kong) Limited 
17. ICBC Credit Suisse Asset Management (International) Company Limited 
18. Instinet
19. Institute of Financial Technologists of Asia (IFTA) 
20. Kingston Financial
21. SQ Capital Group Limited 
22. Tung Tai Group Limited 
23. TUS Corporate Finance Limited
24. United First Partners 
25. Vanguard Investments Hong Kong Limited
26. Vivo Capital 
27. 中投證券國際融資有限公司 
28. 安信國際金融控股有限公司 
29. 國元證券股份有限公司投資銀行總部
30. 尊嘉証券(香港)有限公司 
31. 聊城市東昌府區天元小額貸款股份有限公司 
32. 興業證券股份有限公司
33. 興證國際 
34.  高銀國際(香港)金融集團有限公司
The following corporate finance firms / banks requested anonymity:
35.  Corporate Finance Firm / Bank 1
36. Corporate Finance Firm / Bank 2
37. Corporate Finance Firm / Bank 3
38. Corporate Finance Firm / Bank 4
39. Corporate Finance Firm / Bank 5
40. Corporate Finance Firm / Bank 6
41. Corporate Finance Firm / Bank 7
42. Corporate Finance Firm / Bank 8
43. Corporate Finance Firm / Bank 9
44. Corporate Finance Firm / Bank 10
45. Corporate Finance Firm / Bank 11
46. Corporate Finance Firm / Bank 12
 
Investment Managers
47. Allianz Global Investors Asia Pacific Limited
48. Alternative Investment Management Association
49. BlackRock
50.   BMO Global Asset Management
51. British Columbia Investment Management Corporation
52. Bull Capital Partners (Hong Kong) Limited
53. Capital International, Inc.
54. Capital International, Inc. 
55. China Asset Management (HK) Ltd. 
56. CSOP Asset Management Limited
57. Fidelity International 
58. Hermed Equity Investment Management (Shanghai) Co., Ltd.
59. Hermes Investment Management
60. Huineng Asset Management Limited
61. JW Therapeutics (Shanghai) Co., LTD.
62. Legal & General Investment Management
63. Leucadia Investment Management
64. Norges Bank Investment Management
65. PGGM Investments
66. Yu Ming Investment Management Limited
67. 3H Health Investment Management (HK) Ltd.
68. 上海張江浩成創業投資有限公司
69. 優客工場(北京)創業投資有限公司
70. 常州睿泰投資管理有限公司
71. 廣州市奇源庫投資管理有限公司
72. 時富財富管理有限公司
73. 樸素資本管理有限公司
74. 煙臺創新創業投資有限公司
75. 珠海梧桐領航投資管理有限公司
76. 深圳市前海梧桐併購投資基金管理有限公司
The following investment managers requested anonymity:
77. Investment Manager 1
78. Investment Manager 2
79. Investment Manager 3
80. Investment Manager 4
81. Investment Manager 5
 
Law Firms
82. Beijing DHH Law Firm
83. Eversheds Sutherland
84. Hogan Lovells
85. Jeffrey Mak Law Firm
86. Jones Day
87. Latham & Watkins
88. Locke Lord
89. Mayer Brown JSM
90. Miao & Co. (in association with Han Kun Law Offices)
91. Norton Rose Fulbright 
92. Shearman & Sterling
93. Sidley Austin LLP 
94. Skadden, Arps, Slate, Meagher & Flom
95. Slaughter and May
96. Sullivan & Cromwell (Hong Kong) LLP
97. 漢坤律師事務所 - 深圳 
98. 通商律師事務所 
The following law firms requested anonymity:
99. Law Firm 1
100. Law Firm 2
101.  Law Firm 3
102. Law Firm 4
103. Law Firm 5
104. Law Firm 6
   
Listed Companies
105. Cathay Pacific Airways Limited
106. Great Eagle Holdings Limited
107. Hong Kong Aircraft Engineering Company
108. Sinochem Hong Kong (Group) Co. Ltd.
109. Swire Pacific Limited
110. Swire Properties Limited
The following listed company requested anonymity:
111. Listed Company 1
   
Other Institutions
112. ACEA 
113. AIMA Life-Tech (Shanghai) Ltd. 
114. Ally Bridge LB Healthcare Fund
115. Aptorum Group Limited
116. Aucta Pharmaceuticals
117. B Action Company Limited 
118. BFC Group 
119. BioLingus GmbH 
120. China Insights Consultancy
121. China Resources Pharmaceutical Group Limited 
122. Civic Party
123. dMed Biopharmaceutical Co., Ltd.
124. Financial Services Development Council
125. Florida State Board of Administration
126. GenoSaber Biotech 
127. Global Legal Entity Identifier Foundation (GLEIF) 
128. Gortune Limited 
129. Hong Kong Baptist University - Department of Accountancy & Law 
130. Hua Medicine
131. Investor Education Centre
132. Micurx Pharmaceuticals 
133. Nan Fung Group (Nan Fung Life Sciences) 
134. Office of the Hon. Charles Mok, Legislative Councillor (IT)
135. Office of the Hon. CHEUNG Wah-fung, Legislative Councillor (Financial Services)
136. Office of the Hon. Kenneth Leung, Legislative Councillor (Accountancy)
137. Our Hong Kong Foundation
138. PlantaRx Limited
139. Sanwa Biotech Ltd.
140. The European Chamber of Commerce in Hong Kong
141. Time Medical Corp
142. Time Medical Limited
143. Viva Biotech Ltd. 
144. 上海帕尼生物科技有限公司 
145. 上海海抗中醫藥科技發展有限公司 
146. 北京中十盈信息諮詢有限公司
147. 北京寬厚醫藥科技有限公司 
148. 北京智充科技有限公司 
149. 北京首鋼朗澤新能源科技有限公司 
150. 固高科技集團 
151. 天士力醫藥集團股份有限公司 
152. 東建國際 
153. 東曜藥業有限公司
154. 江蘇淩雲國際
155. 深圳市中農網有限公司 
156. 深圳市小橙堡文化傳播有限公司
157. 碧沃豐生物科技股份有限公司 
158. 藍濤亞洲 
159. 蘇港青年交流促進會
160. 陝西佰美基因股份有限公司 
161. 香港發現者機器人有限公司
   
The following institutions requested anonymity: 
162. Institution 1
163. Institution 2
164. Institution 3
165. Institution 4
166. Institution 5
167. Institution 6
168. Institution 7
169. Institution 8
170. Institution 9
171. Institution 10
172. Institution 11
173. Institution 12
174. Institution 13
175. Institution 14
176. Institution 15
177. Institution 16
178. Institution 17
179. Institution 18
180. Institution 19
181. Institution 20
182. Institution 21
183. Institution 22
184. Institution 23
185. Institution 24
186. Institution 25
187. Institution 26
188. Institution 27
189. Institution 27
190. Institution 28
191. Institution 29
192. Institution 30
193. Institution 30
194. Institution 31
195. Institution 32
196. Institution 33
197. Institution 34 
198. Institution 34
199. Institution 35
   
Professional Bodies / Industry Associations 
200. ACCA Hong Kong 
201. Asia Securities Industry & Financial Markets Association - Asset Management Group 
202. Asia Securities Industry & Financial Markets Association - Equity Capital Markets Committee 
203. Asian Corporate Governance Association
204. Australian Council of Superannuation Investors 
205.  Chamber of Hong Kong Listed Companies
206. Council of Institutional Investors
207. Hong Kong General Chamber of Commerce
208. Hong Kong Institute of Chartered Secretaries
209. Hong Kong Institute of Directors
210. Hong Kong Investment Funds Association (HKIFA)
211. Hong Kong Professionals and Senior Executives Association
212. Hong Kong Securities Association Limited
213. Hong Kong Securities Professionals Association
214. Hong Kong Society of Financial Analysts
215. Hong Kong Venture Capital and Private Equity Association 
216. International Corporate Governance Network 
217. Law Society of Hong Kong
218. Law Society of Hong Kong’s supplemental submission
219. The British Chamber of Commerce in Hong Kong
220. The Institute of Financial Planners of Hong Kong 
221. Y. Elites Association 
222. Y. Elites Association 
223. 香港中國企業協會上市公司委員會 
   
Individuals
 
Institutional Investor Staff
224. Jin Rui Oh 
225. 秦波 
   
Individual Investors 
226. Way Lau
227. Individual Investor 1
   
Other Individuals
228. Basil Hwang 
229. Cassie Chen 
230. Charles Hsu 
231. Chris Song 
232. CY Wong
233. CY Zhao 
234. Danyi Wen 
235. Doris Jiang 
236. Eric Wu 
237. Jimmy Mak 
238. Jimmy Zhang 
239. Judy Tsui 
240. Judy Zhu 
241. Jun Bao 
242. Kaipeng Xia 
243. Karen Liu 
244. Lance Wong
245. Leven Li
246. Liang LIN (Stephen) 
247. Ling Hu Ming 
248. Matthew Harrison
249. Nan Li
250. Nick Tse
251. Nova Liu
252. Patrick Sik Ming Yuen
253. Robin Fox 
254. Sherry He 
255. Silong Zhou 
256. Stella SHI 
257. Steve Chen 
258. Su Linlin 
259. William Cao 
260. Yali Zhu
261. 劉建華 
262. 傅昺
263. 徐斌 
264. 潘君宇 
265. 謝佩靜 
266. 陳治中 
267. 陳秋亦 
268. 齊念民 
Other respondents who requested anonymity:
269. Respondent 1
270. Respondent 2
271. Respondent 3
272. Respondent 4
273. Respondent 5
274. Respondent 6
275. Respondent 7
276. Respondent 8
277. Respondent 9
278. Respondent 10
279. Respondent 11
280. Respondent 12
281. Respondent 13
282.  Respondent 14
283.  Respondent 15
   
Responses received after consultation concluded
Deloitte Touche Tohmatsu
   

Updated 10 May 2018

Loading